SECsense Logo

Solid Biosciences Inc. 8-K Report: Key Events on February 18, 2025

$SLDB
Form 8-K
Filed on: 2025-02-18
Source
Solid Biosciences Inc. 8-K Report: Key Events on February 18, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Solid Biosciences Inc.
  • CIK (Central Index Key): 0001707502
  • SEC File Number: 001-38360
  • EIN (Employer Identification Number): 90-0943402
  • Address: 500 Rutherford Avenue, Third Floor, Charlestown, MA 02129
  • Phone Number: (617) 337-4680
  1. Report Type:
  • Filing Type: 8-K (This indicates a report of unscheduled material events or corporate changes.)
  1. Filing Date:
  • Date of Report: February 18, 2025
  1. Securities Information:
  • Common Stock Par Value: $0.001 per share
  • Ticker Symbol: SLDB
  • Exchange: NASDAQ
  1. Period Context:
  • Reporting Period: The report is for a single day, February 18, 2025.
  1. XBRL Context:
  • The document is formatted in XBRL (eXtensible Business Reporting Language), which is used for financial reporting to improve the accessibility and usability of financial data.

Insights:

  • The report indicates that Solid Biosciences Inc. is actively reporting on significant events or changes, as denoted by the 8-K filing, which is typically used to inform investors about key developments that could impact the company's stock price.
  • The inclusion of financial data in XBRL format suggests a commitment to transparency and compliance with SEC regulations, facilitating easier data analysis for investors and analysts.
  • The par value of the common stock and the listing on NASDAQ indicate that the company is publicly traded, which may affect its reporting obligations and market perception.

This summary captures the essential details of the financial report, highlighting the company's identity, filing specifics, and implications for investors.